(Q44773929)

English

Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michelle P. McIntosh

object named as

Michelle P McIntosh

1

0 references

William N. Charman

object named as

William N Charman

5

0 references

author name string

Andrew J Batey

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Susan J Coker

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Christopher J H Porter

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

69-77

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Clinical pharmacokinetics of halofantrine

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Cardiac effect of halofantrine

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivo.

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Pharmacokinetics of halofantrine in man: effects of food and dose size

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Cardiac complications of halofantrine: a prospective study of 20 patients

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Cardiac effects of antimalarial treatment with halofantrine

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions

1 reference

https://api.crossref.org/works/10.1211%2F0022357022520

21 January 2018

Identifiers

10.1211/0022357022520

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44773929&oldid=2040291971"